Abstract
Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.
Keywords: Heterocyclic N-oxides, N-oxide compounds, tuberculosis, malaria, neglected tropical diseases, leishmaniasis, Chagas disease, drug discovery.
Current Pharmaceutical Design
Title:Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases
Volume: 24 Issue: 12
Author(s): Guilherme Felipe dos Santos Fernandes, Aline Renata Pavan and Jean Leandro dos Santos*
Affiliation:
- Sao Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara,Brazil
Keywords: Heterocyclic N-oxides, N-oxide compounds, tuberculosis, malaria, neglected tropical diseases, leishmaniasis, Chagas disease, drug discovery.
Abstract: Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.
Export Options
About this article
Cite this article as:
dos Santos Fernandes Felipe Guilherme, Pavan Renata Aline and dos Santos Leandro Jean *, Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases, Current Pharmaceutical Design 2018; 24 (12) . https://dx.doi.org/10.2174/1381612824666180417122625
DOI https://dx.doi.org/10.2174/1381612824666180417122625 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preparation and Characterization of A Nanoliposomal Vaccine of pcLACK Candidate Against Cutaneous Leishmaniasis
Infectious Disorders - Drug Targets Molecular Detection of Bacteria Producing Newer Types of β-Lactamases
Current Genomics The Human Trypanolytic Factor: A Drug Shaped Naturally
Infectious Disorders - Drug Targets Infection-Associated Biomarkers of Inflammation in Atherosclerosis
Current Pharmaceutical Design Cathelicidins: Peptides with Antimicrobial, Immunomodulatory, Anti- Inflammatory, Angiogenic, Anticancer and Procancer Activities
Current Protein & Peptide Science New Targets, New Hope: Novel Drug Targets for Curbing Malaria
Mini-Reviews in Medicinal Chemistry The Spectrum of Cefditoren for Lower Respiratory Tract Infections (LRTIs) in Surabaya
Current Drug Therapy Molecular Docking Evaluation of Imidazole Analogues as Potent Candida albicans 14α-Demethylase Inhibitors
Current Computer-Aided Drug Design Recent Patents and Advances on Anti - Tuberculosis Drug Delivery and Formulations
Recent Patents on Drug Delivery & Formulation Association Between Polymorphism of SDF1 (CXCL12) Gene and HIV-1 Susceptibility: A Meta-Analysis
Current HIV Research Structure-based Discovery of Novel Antibacterials
Anti-Infective Agents in Medicinal Chemistry Cardiac Morbidity in an HIV-1 Lipodystrophy Patient Cohort Expressing the TNF-α-238 G/A Single Nucleotide Gene Polymorphism
Current HIV Research Thiocoumarins and Dithiocoumarins: Advances in Synthesis and Pharmacological Activity
Current Organic Chemistry Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges
Recent Patents on Anti-Infective Drug Discovery Novel Research Strategies of Benzimidazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Antimicrobial Activity of Diazenyl Derivatives: An Update
Current Topics in Medicinal Chemistry Medicinal Chemistry of Drugs with Active Metabolites Following Conjugation
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Current Organic Synthesis